Life Insurance
Consensus Index

AI Consensus Fit Review

Corebridge Financial Life Insurance Fit Review for High-Risk Applicants

Corebridge Financial is a situation-dependent fit for high-risk life insurance applicants.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Corebridge Financial is a situation-dependent fit for high-risk life insurance applicants. Four of seven platforms named it during ranking discovery, with an average listed rank of 4.5 and a best rank of 2. The strongest reason to consider it is a genuine guaranteed-issue fallback: Guaranteed Issue Whole Life accepts applicants roughly ages 50–80 with no health questions, alongside a flexible Select-a-Term ladder with 18 durations. The main limitation is that public evidence does not establish superior impaired-risk underwriting, and independent broker reviews report less aggressive impaired-risk offers in 2024–2025. Guaranteed-issue coverage is capped near $25,000 with a two-year graded death benefit.

Research Snapshot

FieldFinding
Platform mentions in ranking stage4 of 7 platforms (deepseek, google, kimi, perplexity)
Share of included platform responses57.1%
Average listed rank4.5
Best listed rank2
Relevant product/model/planSelect-a-Term / AG Select-a-Term term; Guaranteed Issue Whole Life (GIWL); Quick Issue Term; Quality of Life Insurance
Overall use-case fitGood (3 platforms); Mixed (4 platforms) — 7 platforms analyzed
Research date2026-09-22

Why Corebridge Financial Qualified for This Study

Questions This Section Answers

  • Is Corebridge Financial a good choice for Life Insurance for High-Risk Applicants who expect to be rated or declined?
  • How many AI platforms named Corebridge Financial for high-risk life insurance, and where did it rank?

Corebridge Financial qualified because it satisfies the study's core criterion — a financially established carrier with underwriting pathways that may serve applicants outside preferred-risk profiles — and because four of seven platforms named it during ranking discovery (deepseek, google, kimi, perplexity), giving it a 57.1% share of included platform responses and an average listed rank of 4.5.

The carrier is a large, established U.S. life insurer and retirement provider with rated life insurance subsidiaries [1]. Corebridge reports A+ ratings from S&P and Fitch, A2 from Moody's, and A from AM Best for American General Life Insurance Company and related issuing subsidiaries [2]. AM Best identifies American General Life Insurance Company as a member of the Corebridge Financial rating unit [3], and affirmed an A (Excellent) financial strength rating with a stable outlook in January 2026 [4].

Scale is also documented: one independent review describes Corebridge as one of the largest U.S. life and retirement companies with over $370 billion in assets under management [6]. The brand is not always the legal issuing insurer — Corebridge states that life policies are generally issued by American General Life Insurance Company, except in New York where The United States Life Insurance Company in the City of New York issues them [7].

This report evaluates Corebridge only for the high-risk applicant use case. It is not a broad company review. The full Life Insurance for High-Risk Applicants consensus index compares carriers across this category.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for High-Risk Applicants

Questions This Section Answers

  • Which Corebridge Financial product should a high-risk applicant choose if they cannot pass any medical underwriting?
  • Does Corebridge Financial offer a no-exam term option for applicants with health conditions, and what are its age and coverage limits?

The most relevant Corebridge product for this use case is Guaranteed Issue Whole Life (GIWL), a final-expense policy with no health questions and no medical exam. Corebridge's own materials describe no-medical-exam access and a limited first-two-year death benefit generally equal to 110% of premiums paid [8], and Corebridge identifies issuing insurers, state availability limitations, and the first-two-year treatment for the product [9].

Corebridge Direct states GIWL is for ages 50 to 80 with guaranteed approval and no health questionnaire [10], with coverage from $5,000 to $25,000 and rates starting at about $22 per month for $5,000 of coverage [11]. One independent review states the total amount of all AGL Guaranteed Issue Whole Life policies on any person cannot exceed $25,000 in aggregate [12]. A separate directory source describes GIWL as available for ages 50 to 85 in some markets [13], which conflicts with the 50–80 range and should be verified.

For applicants who can still pass underwriting, Select-a-Term is the relevant term product. Corebridge describes Select-a-Term as offering 18 term periods, including 10-year, 35-year, and intermediate durations [14], and states its term life offering includes 18 term periods [15]. Independent reviews describe terms from 10 years up to 35 years with 16 incremental choices in between, available to buyers between ages 18 and 80 [16].

Quick Issue Term is a third pathway: one review describes it as Corebridge's no-medical-exam term product offering up to $500,000 of coverage for healthy applicants ages 18–59 with same-day or next-day underwriting decisions [19]. Note the qualifier "healthy" — this is not a guaranteed-issue term product.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Corebridge Financial's guaranteed-issue whole life coverage limits and waiting period?
  • Is Corebridge Financial financially strong enough for a high-risk applicant buying permanent coverage?

Platforms broadly agreed on four points.

Guaranteed-issue structure. Multiple platforms independently described the same GIWL architecture: no health questions, no medical exam, limited face amounts, and a two-year graded death benefit. Corebridge's own disclosure states the first-two-year death benefit is generally 110% of premiums paid [21]. Independent reviews confirm the standard guaranteed-issue structure of a two-year graded death benefit, with 110% of premiums returned if death from natural causes occurs in the first two years [22]. One review notes that because there are no medical questions, conditions like COPD, heart failure, dialysis, cancer history, and dementia do not affect approval [24].

Coverage cap. The $25,000 aggregate ceiling was reported consistently. One independent review states the total of all AGL Guaranteed Issue Whole Life policies on any person cannot exceed $25,000 in aggregate [25]. Corebridge Direct lists coverage from $5,000 to $25,000 [26].

Financial establishment. Corebridge reports A+ (S&P, Fitch), A2 (Moody's), and A (AM Best) ratings for its principal issuing subsidiaries [27]. AM Best affirmed an A (Excellent) financial strength rating with a stable outlook in January 2026 [28].

Term flexibility. Select-a-Term's 18 durations were confirmed by both company and independent sources [30].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Has Corebridge Financial's underwriting for impaired-risk applicants become less competitive since 2024?
  • Is Corebridge Financial's SimpliNow Choice platform reliable for applicants with complex health profiles?

Platform fit ratings split: three platforms rated Corebridge a "good" fit (openai, anthropic, google) and four rated it "mixed" (deepseek, grok, kimi, perplexity). The disagreements cluster around four issues.

Underwriting aggressiveness over time. One independent broker review states Corebridge has historically been strong with high-risk underwriting [34] but reports that in 2024–2025 less aggressive offers for impaired risk have been observed, with some previously favorable niches like heart disease now hit or miss [36]. Another review states Corebridge has some of the best underwriting for higher-risk customers other companies do not want to insure [38]. These are conflicting independent assessments, and no public, independently audited comparison was found showing Corebridge's approval rates, table-rating practices, decline rates, or premiums for high-risk applicants.

SimpliNow Choice reliability. One review states Corebridge offers real-time approvals on Select-a-Term policies via SimpliNow Choice [39], with telemed or electronic interview options and potential same-day approval [40]. The same source states SimpliNow often declines healthy applicants for vague reasons and is not reliable for even slightly complex health profiles [41].

Simplified-issue term availability. Deepseek reported that public sources reviewed do not confirm whether Corebridge offers any simplified-issue or no-exam term option for high-risk applicants, and that Corebridge's published materials emphasize fully underwritten products [43]. This conflicts with other platforms' descriptions of Quick Issue Term and Agile Underwriting+.

Financial-strength rating status. AM Best affirmed the A (Excellent) rating in January 2026 [45], but subsequently placed the rating under review with developing implications following the announcement that Corebridge entered a definitive agreement to combine with Equitable Holdings on March 26, 2026 [46]. The outcome is not yet determined.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What underwriting pathways does Corebridge Financial offer a high-risk applicant, and which one applies to a specific health condition?
  • Does Corebridge Financial's Select-a-Term include conversion rights to permanent coverage without a new medical exam?

Corebridge offers three underwriting pathways relevant to this use case.

Guaranteed issue. GIWL requires no exam and no health questions for eligible applicants, with premiums fixed for life, coverage that never expires as long as premiums are paid, and a small cash value [48]. Accidental death is typically covered at full benefit from day one, while natural-cause deaths in the first two years pay a graded amount [50].

Accelerated underwriting. Corebridge states that Agile Underwriting is available for certain term, indexed universal life, and guaranteed universal life policies [52]. One review states more than 60% of term life applications qualify for the AU+ streamlined process [53], and another states over 60% of term applications qualify for AU+ but the final decision may require labs or records [54]. Corebridge itself explains that simplified underwriting may avoid a medical exam but approval is not guaranteed and coverage may be more restricted [55]. One underwriting guide excerpt describes AU+ eligibility criteria and full underwriting triggers [56], and a broker guide states Corebridge's underwriting rules determine whether an applicant can bypass examinations using AU+ based on medical and prescription databases [57].

Traditional full underwriting. Select-a-Term typically requires a paramedical exam for face amounts above $500,000 or for applicants with health conditions [58].

Additional features reported by platforms:

  • Flex Points. Launched in 2024, Flex Points replaced the Health Credits program, and credits are automatically applied to help borderline cases qualify for better pricing [59]. Specific dollar impact is not publicly quantified.
  • Conversion. Select-a-Term includes a conversion credit reducing first-year permanent premiums if converted to a universal life policy within the first 8 to 10 years [61]. One review notes Select-a-Term conversion to permanent insurance is available without a medical exam within a specified timeframe [62].
  • Living benefits. Quality of Life Insurance is universal life with chronic-illness living benefits, typically taking 4 to 8 weeks due to comprehensive underwriting [63].
  • Term duration flexibility. Select-a-Term's 18 durations let applicants match coverage to a mortgage, income-replacement period, or other obligation [65].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Corebridge Financial's Guaranteed Issue Whole Life cost per month, and what fees apply?
  • Are Corebridge Financial's term rates competitive for a high-risk applicant compared with other carriers?

Pricing confidence varies sharply by product. GIWL pricing is the best documented; term and permanent pricing is largely quote-driven.

Guaranteed Issue Whole Life. Corebridge Direct lists rates starting at about $22 per month for $5,000 of coverage at age 50 [68]. One platform reported sample rates of $22 per month for a 50-year-old female and $32 per month for a 50-year-old male for $5,000 of coverage [69]. Another reported $21 per month female age 50 and $29 per month male age 50 for $5,000 [70]. These figures conflict slightly and should be confirmed by quote. One rate sheet lists a $24 annual policy fee [71]. Premiums are fixed for life and guaranteed not to increase [72].

Term. One platform reported a sample Select-a-Term rate of $44.78 per month for a 45-year-old male at Preferred Plus, $500,000 20-year term, noting high-risk rates will scale higher based on actual table ratings [74]. Another reported Select-a-Term examples around $13–$39 per month for $100,000–$250,000 healthy non-smoker term [75]. One platform reported Quick Issue Term samples: a 35-year-old female at $500,000 Select-a-Term 20-year approximately $20–28 per month, versus approximately $24–32 per month for the same applicant no-exam [76]. These are platform-reported examples, not verified quotes.

Permanent. One review states Corebridge's universal life insurance rates run higher than several competitors at comparable coverage levels [77]. Another states guaranteed-issue premium cost is higher compared to other policies with similar face amounts because there is virtually no underwriting and Corebridge is absorbing significant risk [78].

Contract terms. GIWL has a two-year graded death benefit [80]. One platform reported a 31-day grace period (60 days in California), with reinstatement possibly requiring new underwriting [75]. Another reported GIWL lapses without notice if payment is late more than 60 days [71]. Exact free-look periods, surrender values, renewal terms, and rider costs were not verified for each product and must be confirmed in the policy illustration and contract.

Best Suited For

Questions This Section Answers

  • Who is Corebridge Financial's Guaranteed Issue Whole Life actually designed for?
  • Which high-risk applicant profile gets the most value from Corebridge Financial's Select-a-Term product?

Corebridge is best suited to three buyer profiles.

Applicants ages 50–80 who cannot pass any underwriting. GIWL accepts applicants with no health questions and no exam, including those with severe conditions [81]. This is the clearest fit.

Applicants with health or lifestyle risks who can still undergo underwriting. Select-a-Term and permanent products provide broader coverage possibilities if the applicant can qualify [84]. One review states Corebridge is more accessible than most insurers for applicants with health conditions [86].

Applicants who need a specific term length. Select-a-Term's 18 durations, from 10 to 35 years, allow precise matching of coverage to a financial obligation [87].

Applicants prioritizing carrier establishment. Corebridge's reported investment-grade ratings and scale support the "financially established carrier" criterion [90].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Corebridge Financial for Life Insurance for High-Risk Applicants?
  • Is Corebridge Financial a poor fit for a high-risk applicant who needs more than $25,000 of guaranteed coverage?

Corebridge is probably not the best fit for several profiles.

Applicants needing large guaranteed death benefits. GIWL is capped at $25,000 in aggregate [92], which is insufficient for income replacement or estate-liquidity needs.

Applicants who need immediate full death benefits. The two-year graded period materially reduces early protection [93].

Applicants seeking traditional whole life. One review states Corebridge does not offer traditional whole life insurance, with its permanent lineup limited to universal, indexed universal, variable universal, and final expense products [95].

Applicants with complex health profiles using SimpliNow. One review states SimpliNow is not reliable for even slightly complex health profiles [97].

Applicants in previously favorable niches now uncertain. Heart disease and similar conditions are described as hit or miss in 2024–2025 [98].

Digital-first buyers. One review states there is no self-serve online application; buyers initiate by phone or website form, then work with an agent [99].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Corebridge Financial for a high-risk applicant who needs more than $25,000 of guaranteed coverage?
  • When should a high-risk applicant use an independent broker instead of applying directly to Corebridge Financial?

Another option may be better in five situations.

When a more favorable tentative decision is available elsewhere. Another carrier may offer a more favorable tentative underwriting decision for the applicant's specific diagnosis, treatment history, build, tobacco use, occupation, or aviation/hobby risk [100].

When the applicant needs high coverage limits. An applicant who can qualify for medically underwritten term or permanent insurance may find better pricing and larger face amounts elsewhere [100].

When a different guaranteed-issue structure fits better. An applicant who wants different age limits, higher face amounts, or a shorter graded-benefit period should compare other guaranteed-issue carriers [100]. One source recommends starting with simplified issue rather than guaranteed issue, since simplified issue is less expensive and provides immediate full coverage [101].

When the applicant needs broker comparison. An applicant who needs a broker to compare multiple impaired-risk carriers rather than relying on one carrier's product set should work with an independent broker [100].

When the applicant is younger than 50. The verified GIWL product is age-limited to 50–80, so younger high-risk buyers need a different pathway [102].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Corebridge Financial before signing a high-risk life insurance contract?
  • Which legal insurer will issue the Corebridge Financial policy, and what are its current ratings?

Verify these items before submitting an application or signing a contract.

  1. Which legal insurer will issue the policy in the applicant's state, and what are its current financial-strength ratings? [104]
  2. Does the applicant qualify for Select-a-Term, simplified issue, accelerated underwriting, or only Guaranteed Issue Whole Life? [106]
  3. What specific medical, lifestyle, occupation, tobacco, aviation, or hazardous-activity exclusions or surcharges apply? [108]
  4. What are the maximum face amount, issue-age range, premium schedule, and two-year death-benefit terms for the guaranteed-issue product? [109]
  5. Does the guaranteed-issue policy pay 110% of premiums during the first two years for all non-accidental deaths, and are there state-specific variations? [108]
  6. Are premiums level and guaranteed for the full term or life of the policy? [112]
  7. What conversion rights, renewal terms, surrender values, policy-loan provisions, and rider costs apply? [114]
  8. Is a medical exam, APS record, prescription check, or financial/occupational review required despite an accelerated or simplified-issue pathway? [116]
  9. Would an independent broker obtain tentative offers from other impaired-risk carriers before submitting a formal application? [108]
  10. What happens if the applicant is rated, postponed, or declined, and can the application be withdrawn without creating an adverse underwriting record with other carriers? [108]
  11. Will existing policy coverage, rights, and guarantees remain intact regardless of the Equitable merger completion timeline or rating review outcome? [118]
  12. Is the $25,000 aggregate limit per insurer or across all carriers, and can the applicant obtain separate policies from multiple insurers? [109]

Final AI Consensus Verdict

Corebridge Financial is a good but situation-dependent fit for high-risk life insurance applicants. The strongest case is an applicant who needs a financially established carrier and a guaranteed-issue final-expense fallback, or an applicant whose risks may still fit Corebridge's term or permanent underwriting. Four of seven platforms named it during ranking discovery, with an average listed rank of 4.5 and a best rank of 2.

It is not clearly the best option for every high-risk applicant. Public evidence does not verify superior impaired-risk underwriting, guaranteed-issue coverage has materially limited early benefits and a $25,000 aggregate cap, and pricing and eligibility are highly individualized. Independent broker reviews report less aggressive impaired-risk offers in 2024–2025, and the AM Best rating is under review pending a merger with Equitable Holdings. Buyers should verify their specific risk profile against current underwriting appetite and compare specialist high-risk carriers before applying.

How This Review Was Produced

This review synthesizes fit-research responses from seven AI platforms (openai, anthropic, deepseek, google, grok, kimi, perplexity) collected for the topic "Best Life Insurance Companies for High-Risk Applicants." The authoritative run research date is 2026-09-22. Platform mentions in the ranking stage count only platforms that named Corebridge Financial during ranking discovery; all seven platforms evaluated fit, but only four named the entity in ranking. Platform fit ratings were three "good" and four "mixed." Citations are platform-reported evidence, not independently verified facts. Company-owned sources are distinguished from independent sources throughout.

Methodology Limitations

Several limitations apply. Platform-reported research dates differ from the authoritative run date: deepseek reported 2026-01-15, while the other six platforms reported 2026-09-23. These dates are provenance metadata and do not independently prove freshness. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. One or more fetched domains were not corroborated by brand-name or site-identity metadata and were not used as official identity signals; company-name variants were collapsed onto one canonical brand before minimum-mentions qualification. The reviewed sources do not publish a complete, current underwriting guide for high-risk medical conditions or hazardous occupations. No public, independently audited comparison was found showing Corebridge's approval rates, table-rating practices, decline rates, or premiums for high-risk applicants. Exact guaranteed-issue face amounts, age limits, premium schedules, rider availability, and state approvals were not verified from the reviewed sources. Financial-strength ratings can change. Platform agreement does not prove product quality. No personal testing, customer experience, or independent verification was performed.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Additional AI research evidence119 records
    1. AI research evidence record deepseek:c1
    2. AI research evidence record openai:c7
    3. AI research evidence record openai:c8
    4. AI research evidence record anthropic:20-4
    5. AI research evidence record anthropic:20-5
    6. AI research evidence record anthropic:8-13
    7. AI research evidence record openai:c2
    8. AI research evidence record openai:c1
    9. AI research evidence record openai:c2
    10. AI research evidence record perplexity:c3
    11. AI research evidence record perplexity:c2
    12. AI research evidence record anthropic:11-1
    13. AI research evidence record google:1.1.4
    14. AI research evidence record openai:c5
    15. AI research evidence record openai:c6
    16. AI research evidence record anthropic:46-1
    17. AI research evidence record anthropic:46-2
    18. AI research evidence record anthropic:46-3
    19. AI research evidence record anthropic:8-2
    20. AI research evidence record anthropic:8-3
    21. AI research evidence record openai:c1
    22. AI research evidence record anthropic:36-2
    23. AI research evidence record anthropic:36-3
    24. AI research evidence record anthropic:36-1
    25. AI research evidence record anthropic:11-1
    26. AI research evidence record perplexity:c2
    27. AI research evidence record openai:c7
    28. AI research evidence record anthropic:20-4
    29. AI research evidence record anthropic:20-5
    30. AI research evidence record openai:c5
    31. AI research evidence record openai:c6
    32. AI research evidence record anthropic:46-1
    33. AI research evidence record anthropic:46-2
    34. AI research evidence record anthropic:4-4
    35. AI research evidence record anthropic:4-9
    36. AI research evidence record anthropic:4-10
    37. AI research evidence record anthropic:4-11
    38. AI research evidence record anthropic:34-5
    39. AI research evidence record anthropic:30-7
    40. AI research evidence record anthropic:30-8
    41. AI research evidence record anthropic:30-9
    42. AI research evidence record anthropic:30-10
    43. AI research evidence record deepseek:c2
    44. AI research evidence record deepseek:c4
    45. AI research evidence record anthropic:20-4
    46. AI research evidence record anthropic:25-1
    47. AI research evidence record anthropic:25-3
    48. AI research evidence record anthropic:15-1
    49. AI research evidence record anthropic:8-7
    50. AI research evidence record kimi:asurgo-1
    51. AI research evidence record kimi:asurgo-2
    52. AI research evidence record openai:c3
    53. AI research evidence record anthropic:33-11
    54. AI research evidence record anthropic:4-5
    55. AI research evidence record openai:c4
    56. AI research evidence record grok:1
    57. AI research evidence record google:1.3.3
    58. AI research evidence record anthropic:43-5
    59. AI research evidence record anthropic:4-6
    60. AI research evidence record anthropic:4-8
    61. AI research evidence record google:1.2.5
    62. AI research evidence record anthropic:1-1
    63. AI research evidence record anthropic:34-3
    64. AI research evidence record anthropic:43-15
    65. AI research evidence record openai:c5
    66. AI research evidence record anthropic:10-3
    67. AI research evidence record anthropic:10-5
    68. AI research evidence record perplexity:c2
    69. AI research evidence record google:1.1.3
    70. AI research evidence record perplexity:c8
    71. AI research evidence record anthropic:11-1
    72. AI research evidence record anthropic:15-1
    73. AI research evidence record perplexity:c6
    74. AI research evidence record google:1.2.2
    75. AI research evidence record grok:17
    76. AI research evidence record anthropic:8-3
    77. AI research evidence record anthropic:12-1
    78. AI research evidence record anthropic:17-6
    79. AI research evidence record anthropic:17-8
    80. AI research evidence record anthropic:36-2
    81. AI research evidence record anthropic:36-1
    82. AI research evidence record perplexity:c1
    83. AI research evidence record perplexity:c3
    84. AI research evidence record openai:c3
    85. AI research evidence record anthropic:2-5
    86. AI research evidence record anthropic:6-2
    87. AI research evidence record openai:c5
    88. AI research evidence record anthropic:46-1
    89. AI research evidence record anthropic:46-2
    90. AI research evidence record openai:c7
    91. AI research evidence record anthropic:8-13
    92. AI research evidence record anthropic:11-1
    93. AI research evidence record anthropic:36-2
    94. AI research evidence record anthropic:36-3
    95. AI research evidence record anthropic:12-5
    96. AI research evidence record anthropic:12-6
    97. AI research evidence record anthropic:30-10
    98. AI research evidence record anthropic:4-11
    99. AI research evidence record anthropic:28-11
    100. AI research evidence record openai:c1
    101. AI research evidence record kimi:asurgo-2
    102. AI research evidence record perplexity:c1
    103. AI research evidence record perplexity:c3
    104. AI research evidence record openai:c2
    105. AI research evidence record openai:c7
    106. AI research evidence record openai:c3
    107. AI research evidence record openai:c4
    108. AI research evidence record openai:c1
    109. AI research evidence record anthropic:11-1
    110. AI research evidence record perplexity:c2
    111. AI research evidence record anthropic:36-3
    112. AI research evidence record anthropic:15-1
    113. AI research evidence record perplexity:c6
    114. AI research evidence record google:1.2.5
    115. AI research evidence record anthropic:1-1
    116. AI research evidence record anthropic:4-5
    117. AI research evidence record google:1.3.3
    118. AI research evidence record anthropic:25-1
    119. AI research evidence record anthropic:25-3

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
51
Ranking mentions
4 of 7
Platform share
57%
Final consensus rank
#6

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

34 independent · 16 company-owned · 1 unclear

Evidence support

29 direct · 9 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

b1fee247800fb9f2f27b0af483dc4e1f0ede2c2c13a99a3467c463ae5f9e0f2a